Dow Tumbles Over 250 Points; Boeing Posts Q3 Loss
Dow Tumbles Over 250 Points; Boeing Posts Q3 Loss
U.S. stocks traded lower this morning, with the Dow Jones index dipping more than 250 points on Wednesday.
美國股市在今早交易下跌,道瓊斯指數週三下跌超過250點。
Following the market opening Wednesday, the Dow traded down 0.63% to 42,654.26 while the NASDAQ fell 0.47% to 18,486.46. The S&P 500 also fell, dropping, 0.33% to 5,831.63.
週三開盤後,道瓊斯指數下跌0.63%,至42,654.26點,納斯達克指數下跌0.47%,至18,486.46點。標普500指數也下跌0.33%,至5,831.63點。
Leading and Lagging Sectors
Utilities shares rose by 0.5% on Wednesday.
領漲與跌幅最大的板塊:
週三公用事業股上漲0.5%。
In trading on Wednesday, consumer discretionary shares fell by 0.9%.
週三消費者自由股下跌0.9%。
Top Headline
頭條新聞:
Boeing Co (NYSE:BA) reported a loss for the third quarter on Wednesday.
波音公司(紐交所: BA)週三報告第三季度虧損。
The company posted a 1% year-over-year revenue decline to $17.854 billion in the third quarter of 2024, missing the consensus of $17.931 billion. Adjusted loss per share expanded to $10.44 from $3.62 in the same quarter of 2023, missing the consensus of $10.34.
該公司在2024年第三季度的營業收入同比下降1%,至178.54億美元,低於179.31億美元的共識。每股調整後虧損從2023年同季度的3.62美元擴大至10.44美元,低於10.34美元的共識。
Equities Trading UP
股票上漲:
- La Rosa Holdings Corp. (NASDAQ:LRHC) shares shot up 164% to $1.3300 after the company reported preliminary 9-moth revenue growth of 120% year over year.
- Shares of CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) got a boost, surging 90% to $0.2979. The company requested a panel hearing for November 5, 2024, and will be subject to a halt in the suspension or delisting decision until then.
- Virax Biolabs Group Limited (NASDAQ:VRAX) shares were also up, gaining 87% to $3.1197 after the company announced a distribution agreement with Europa Biosite to commercialize the ImmuneSelect research-use portfolio in the United Kingdom and Ireland.
- La Rosa控股有限公司(納斯達克:LRHC)股票價格飆升164%,至1.3300美元,公司報告顯示,年度營業收入增長120%。
- cns pharmaceuticals股票(納斯達克:CNSP)獲得提振,漲幅90%,至0.2979美元。公司要求11月5日進行專家聽證會,並將在那之前暫停或停止除牌決定。
- Virax Biolabs集團有限公司(納斯達克:VRAX)股價也上漲,漲幅87%,至3.1197美元,公司宣佈與Europa Biosite達成分銷協議,以在英國和愛爾蘭商業化ImmuneSelect研究用產品組合。
Equities Trading DOWN
股票下跌:
- Alto Neuroscience, Inc. (NYSE:ANRO) shares dropped 62% to $5.53 after the company announced topline results from a Phase 2b trial evaluating ALTO-100 as a treatment for major depressed disorder did not meet its primary endpoint.
- Shares of Ensysce Biosciences, Inc. (NASDAQ:ENSC) were down 26% to $0.3960.
- Aptevo Therapeutics Inc. (NASDAQ:APVO) was down, falling 26% to $0.2616.
- Alto Neuroscience公司(紐交所:ANRO)股價下跌62%,至5.53美元,公司宣佈從一項評估ALTO-100作爲治療重大抑鬱症的第20億階段試驗的最終數據未達到主要終點。
- Ensysce生物科技公司股票(納斯達克:ENSC)下跌26%,至0.3960美元。
- Aptevo治療學公司股票(納斯達克:APVO)下跌26%,至0.2616美元。
Commodities
In commodity news, oil traded down 1.3% to $70.80 while gold traded down 0.5% at $2,747.40.
商品雜項
在商品新聞中,原油下跌1.3%,至70.80美元,黃金下跌0.5%,至2,747.40美元。
Silver traded down 2.5% to $34.180 on Wednesday, while copper fell 1.3% to $4.3240.
白銀週三下跌2.5%,至34.180美元,而銅下跌1.3%,至4.3240美元。
Euro zone
歐元區:
European shares were mostly lower today. The eurozone's STOXX 600 fell 0.2%, Germany's DAX fell 0.2% and France's CAC 40 fell 0.5%. Spain's IBEX 35 Index rose 0.1%, while London's FTSE 100 fell 0.5%.
歐洲股市今天大部分走低。歐元區的STOXX 600下跌0.2%,德國的DAX下跌0.2%,法國的CAC 40下跌0.5%。西班牙的IBEX 35指數上漲0.1%,而倫敦的FTSE 100下跌0.5%。
Asia Pacific Markets
亞太市場
Asian markets closed mixed on Wednesday, with Japan's Nikkei 225 falling 0.80%, Hong Kong's Hang Seng Index gaining 1.27%, China's Shanghai Composite Index gaining 0.52% and India's BSE Sensex falling 0.17%.
週三亞洲市場收盤走勢不一,日本的日經225指數下跌0.80%,香港的恒生指數上漲1.27%,中國的上海綜合指數上漲0.52%,印度的BSE Sensex指數下跌0.17%。
Singapore's annual inflation rate eased to 2.0% in September versus 2.2% in the previous month.
新加坡9月份的年通脹率爲2.0%,而上個月爲2.2%。
Economics
經濟學
U.S. mortgage applications declined by 6.7% from the previous week during the third week of October, following a 17% dip in the earlier period.
美國在十月第三週的抵押貸款申請量較上週下降了6.7%,此前期間下降了17%。
Now Read This:
現在閱讀這個:
- Top 2 Energy Stocks That May Implode This Quarter
- 可能在本季度崩盤的前兩大能源股
譯文內容由第三人軟體翻譯。